Tau and neurodegenerative disease: the story so far
By K. Iqbal, Fei Liu, C. Gong. Nature Reviews Neurology, 2016
720 citations recorded by the source corpus.
Subfields: Molecular Biology, Neurology, Physiology
View Paper: https://www.semanticscholar.org/paper/4741747431cac15fd1f56614d048bf04022c2b79
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Howard Y. Chang
- Luke A. Gilbert
- Jonathan S. Weissman
- Bradley E. Bernstein
- David P. Bartel
- Pedro J. Batista
- Johannes Rinn
- Jennifer A. Doudna
In Neurology
Citations in the corpus
- The world of protein acetylation. (2016, background): “This fibril formation and subsequent formation of insoluble plaques is a major factor in the etiology of Alzheimer's and related diseases, termed tauopathies [442].”
- Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease (2018, background): “In AD brains, 3R and 4R tau is accumulated in a hyperphosphorylated state in the pathological inclusions (Goedert, 1993; Goedert et al., 1996; Serrano-Pozo et al., 2011; Iqbal et al., 2016).”
- Genome-wide Programmable Transcriptional Memory by CRISPR-based Epigenome Editing (2021, methodology): “We next applied CRISPRoff-mediated editing of iPSC-derived neurons to silence MAPT, a gene that encodes the Tau protein and is implicated in various neurological diseases (Iqbal et al., 2016).”